Osteoporosis, Postmenopausal: all 337 studies
Page 3 of 4. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.
- Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy AdultsCompletedNCT03761979Not applicable
- MRI Study of the Distal Radius Bone Marrow Fat Fraction in Osteoporotic and Healthy WomenCompletedNCT03742362Not applicable
- G56W1 in Women With Postmenopausal OsteoporosisStatus unknownNCT03720886Phase 1/2
- Milk Protein and Bone Health in Postmenopausal WomenCompletedNCT03701113Not applicable
- Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVPActive, not recruitingNCT03692143
- Comparative Antiresorptive Efficacy Discontinuation of DenosumabActive, not recruitingNCT03623633Phase 4
- Clinical Study on Treatment of Postmenopausal Osteoporosis (Kidney Deficiency and Blood Stasis Syndrome) With Xulin Jiangu GranulesStatus unknownNCT03563235Early Phase 1
- Association of Serum Ferritin and Bone Mineral Density With Bone Metabolism in Chinese Healthy Postmenopausal WomenStatus unknownNCT03512743
- A Clinical Trial to Evaluate the Safety and PharmacokineticStatus unknownNCT03475719Phase 1
- MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal OsteoporosisCompletedNCT03472846Phase 4
- Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported OutcomesStatus unknownNCT03435094
- Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal WomenStatus unknownNCT03382366Not applicable
- Effects of Vitamin D Supplementation in Muscle Strength and Balance TrainingCompletedNCT03367585Not applicable
- Nutritional Supplement and Bone Health in Post-Menopausal WomenCompletedNCT03337971Not applicable
- Dental Panoramic Radiographs to Screen for Post-menopausal OsteoporosisCompletedNCT03304743
- STRONG - Study of AGN1 LOEP for the Treatment of the Contralateral Femur After Fragility FractureCompletedNCT03268356Not applicable
- Effect of Mechanical Loading With PTH on Cortical BoneWithdrawnNCT03232476Phase 4
- DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older WomenCompletedNCT03227458Not applicable
- The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal WomenStatus unknownNCT03225703Not applicable
- Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic WomenStatus unknownNCT03158246Phase 4
- Validation, Reliability and Pilot Test of the Personalized Exercise Questionnaire (PEQ)CompletedNCT03125590
- Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal WomenCompletedNCT03091088Not applicable
- Moringa Oleifera on Bone DensityCompletedNCT03026660Not applicable
- CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency SyndromeStatus unknownNCT02981732Not applicable
- Peri-implant Bone Changes in Post-menopausal Osteoporotic WomenCompletedNCT02884401Not applicable
- The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP)Status unknownNCT02854722Phase 2
- Dried Plums and Bone Health in Postmenopausal WomenActive, not recruitingNCT02822378Not applicable
- Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal OsteoporosisCompletedNCT02808988Phase 4
- Effect of Blueberries on Bone TurnoverStatus unknownNCT02630797Phase 1/2
- A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or OsteopeniaCompletedNCT02604836Phase 4
- PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or OsteopeniaCompletedNCT02598453Phase 4
- A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal OsteoporosisCompletedNCT02598440Phase 4
- Zoledronic Acid to Maintain Bone Mass After Denosumab DiscontinuationCompletedNCT02499237Phase 4
- A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo PenCompletedNCT02478879Phase 1
- Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis MedicationCompletedNCT02472782
- Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in PakistanCompletedNCT02422069
- Soluble Corn Fiber Effect on Bone Resorption in Post Menopausal WomenCompletedNCT02416947Not applicable
- Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in FranceCompletedNCT02347865
- Observational Study of iv Ibandronate in Women With Postmenopausal OsteoporosisCompletedNCT02271204
- Epidemiology, Identification Rate and Treatment Penetration of Osteoporotic Vertebral Fractures in SwitzerlandCompletedNCT02234414
- Periodontal Disease and Post-menopausal OsteoporosisCompletedNCT02184962
- Quality of the Detection & Treatment of Osteoporotic Fractures in a Swiss Trauma CenterCompletedNCT02157753
- Study on the microRNA Expression Level in Postmenopausal OsteoporosisCompletedNCT02128009
- Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal WomenCompletedNCT02090400Phase 4
- Safety Study of an Oral Vitamin D Analog in Postmenopausal WomenCompletedNCT01969656Phase 1
- Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and ForteoStatus unknownNCT01945788Phase 4
- Hesperidin and Bone Health in Postmenopausal WomenCompletedNCT01881204Not applicable
- Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1Status unknownNCT01834105Phase 2
- Bone Healing in Healthy and Post-menopausal Osteoporotic WomenWithdrawnNCT01826656Not applicable
- Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal OsteoporosisStatus unknownNCT01760798Not applicable
- Mediterranean Diet for Post-menopausal Women: Effects on Bone TurnoverCompletedNCT01653275Not applicable
- Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone MassCompletedNCT01572545Not applicable
- Radius Loading in Primary HyperparathyroidismCompletedNCT01571843Not applicable
- Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)WithdrawnNCT01552122Phase 3
- Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal OsteoporosisCompletedNCT01544894Phase 4
- Open-label Study to Evaluate the Effect of MBP-80 on Bone RemodellingCompletedNCT01501344Not applicable
- Resolution of Effect of Bisphosphonates on Bone in Postmenopausal OsteoporosisCompletedNCT01406613
- Wellnara Post-marketing Surveillance in JapanCompletedNCT01401114
- Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in JapanCompletedNCT01397955
- Julina Post-marketing Surveillance for Climacteric Symptoms in JapanCompletedNCT01386281
- The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal WomenCompletedNCT01381588
- Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal OsteoporosisCompletedNCT01348243Phase 3
- Vitamin K as Additive Treatment in OsteoporosisStatus unknownNCT01232647Phase 2/3
- Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate TreatmentCompletedNCT01227369
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal WomenCompletedNCT01224717Phase 1
- A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal OsteoporosisCompletedNCT01128257
- Angeliq Regulatory Post Marketing SurveillanceCompletedNCT01064453
- Intra-venous Zoledronic Acid Once YearlyCompletedNCT00984893
- A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent FormulationCompletedNCT00965978Phase 1
- A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 YearsCompletedNCT00909961Phase 3
- A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese WomenCompletedNCT00860964Phase 4
- Risedronate vs Raloxifene in Hormone Replacement Therapy DiscontinuationTerminatedNCT00790101Phase 4
- Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or RisedronateCompletedNCT00778154
- A Study for Teriparatide in Severe OsteoporosisCompletedNCT00696644
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal SubjectsCompletedNCT00676312Phase 1
- The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine EvaluationCompletedNCT00674453Phase 2
- Effects of Teriparatide in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00670501Phase 3
- Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00670319Phase 3
- Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential EffectsCompletedNCT00666627Phase 2
- Optimizing Body Composition & Health After Breast CancerCompletedNCT00659906Not applicable
- A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With OsteoporosisCompletedNCT00632216Phase 4
- Strength Training for Older Breast Cancer SurvivorsCompletedNCT00591747Not applicable
- Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal WomenCompletedNCT00578981Not applicable
- Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMOCompletedNCT00577421Phase 3
- Prevention of Osteoporosis in Breast Cancer SurvivorsCompletedNCT00567606Not applicable
- Satisfaction and Compliance of Risedronate in PMOCompletedNCT00549965Phase 4
- POWER Point of Care Effect on Satisfaction of TreatmentCompletedNCT00549068Phase 4
- BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal OsteoporosisCompletedNCT00545909Phase 4
- SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.CompletedNCT00545480Phase 4
- ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.CompletedNCT00545090Phase 4
- PTH Comparison in Post Menopausal WomenCompletedNCT00543218Phase 3
- A Study of the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00543023Phase 3
- Comparison Medications in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00542984Phase 3
- Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)CompletedNCT00533650Phase 2
- Bone Marker Changes With Teriparatide/Postmenopausal OsteoporosisCompletedNCT00532545Phase 4
- Long Term Effects of Raloxifene Treatment on Bone QualityCompletedNCT00532428Phase 4
- Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or PlaceboCompletedNCT00532246Phase 4
- Study of Teriparatide in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00532207Phase 3
- PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)CompletedNCT00515593
- A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.No longer availableNCT00493532